References

BoosConsulting supports, among others, the following categories of clients:
  • Research-based pharmaceutical companies
  • Biotech companies
  • Generic manufacturers
  • Parallel and re-importers
  • Medical device manufacturers
  • Seminar providers
  • Universities
  • Other service providers and expert teams
  • Lawyers/Law firms

  • Therapeutic areas/substances (selection)

    Cardiology (arrhythmias, angina pectoris, hypertension, myocardial infarction, heart failure, loop diuretics)

    CNS (stroke, depression / schizophrenia, multiple sclerosis)

    Endocrinology (Diabetes mellitus product family, thyroids, corticoids, hypercholesterolemia)

    Development substances (metabolic disorders, growth hormones, HIV specialties, recombinant drugs / biopharmaceuticals)

    Oncology (monoclonal antibodies, individualized immunotherapeutics, checkpoint inhibitors)

    Fertility & Women’s Health portfolio (products for infertility treatment, hormone replacement therapy)

    Specialties / Orphan Drugs / Rare Diseases (cyanide poisoning, ethylene glycol intoxication, alcohol dependence, phenylketonuria, SIADH, intermittent claudication, Helicobacter pylori diagnostics, inborn errors in primary bile acid synthesis, primary biliary cholangitis, multiple myeloma, cystic fibrosis)

    Respiratory / Chronic lung diseases (bronchial asthma, allergic rhinitis, COPD)

    Dermatology (skin and mucosal infections, actinic keratosis, superficial basal cell carcinoma, urogenital warts, atopic eczema)

    Pain / Inflammation (rheumatic diseases / osteoarthritis, acute musculoskeletal diseases, breakthrough cancer pain, fibromyalgia, purulent infections of bone / bone marrow)

    Gastroenterology (anorectal inflammation in inflammatory bowel diseases)

    Non-prescription / OTC drugs (cough & cold portfolio, skin infections, halitosis, warts)

    Eye diseases (glaucoma)

    Medical devices & cosmetics


  • Cross-therapeutic activities

    ●  Performing seminars on various topics at a large and renowned seminar provider for many years

    ●  In-house trainings on various pharmacovigilance topics

    ●  Presentations at congresses and conferences (e.g. DGPharMed congress, BADI (Bulgarian Association for Drug Information))

    ●  Lecturer at the Hochschule Fresenius (private university) / Carl Remigius Medical School

    ●  Several years author of the regular column "PV up-to-date" of the journal "PM QM" (Journal of Pharmaceutical Medicine and Quality Management)


Previous employers/clients (selection, in alphabetical order)
  • axicorp GmbH
  • BADI - Bulgarian Association for Drug Information
  • Boehringer Ingelheim
  • DKFZ - German Cancer Research Center
  • EUSA Pharma (UK) Limited
  • FORUM Institute for Management
  • Fresenius University
  • Heidelberg Academy (AKAD)
  • Hormosan
  • Intercept Pharma Ltd.
  • Laboratoires CTRS (Cell Therapies Research & Services)
  • Lupin
  • MEDA Pharma GmbH & Co. KG
  • MedConCap
  • MEGRA - Central European Society for Regulatory Affairs
  • Novartis Pharma AG
  • Otsuka Frankfurt Research Institute
  • Ratiopharm
  • Sanofi-Aventis Germany GmbH
  • STADA
  • TaylorWessing
  • Vertex Pharmaceuticals Inc.

The list of clients will gradually be expanded - provided the respective confidentiality agreements allow it.


The orders for the listed companies included part-time and full-time projects and spanned periods ranging from a few weeks to several years.

Customer testimonials (excerpts from letters of recommendation)
Monika worked for me as a senior Brand Safety Leader for one year. Monika is an excellent communicator, both in writing and verbally. Her outstanding skills are in performance, dedication to task, quick involvement with associates new to her, rapid understanding of what needs to be accomplished, a willingness to help improve processes and templates, and, above all, her integrity in adherence to pharmacovigilance principles.
(Swiss Big Pharma company, one year collaboration)
Dr. Boos was very proactive in supporting the team, always responding quickly to questions, looking for solution.
I appreciated her availability, communication skills and expertise in PV activities related to clinical trials.
(French Biotech enterprise, 12 months collaboration)
Dr. Boos is characterized by her extremely conscientious and independent approach to work. The results of her assessments, drafts, and comments were always very good and helpful. Her work is characterized by a systematic approach. The results were outstanding in every respect.
(German global healthcare company, 3.5 years of collaboration)
Due to her many years of relevant professional experience, Ms. Boos quickly became familiar with the company and its work processes. She always completed the tasks assigned to her with utmost reliability and was very flexible in terms of approach and timing. Her excellent knowledge of the regulatory framework for PV also enabled her to provide targeted suggestions for further developing processes and associated SOPs.
In summary, I strongly recommend Ms. Boos for this or a similar role.
(Scandinavian specialty therapeutics company, 3 years of collaboration)

The letters of recommendation can be provided in full upon request.